Vladimir Putin estimated the neurocap SleepAlert on "Innoprom"

The President of Russia highly appreciated the Russian development  - SleepAlert, implemented by «Neurotone» within the framework of the National Technology Initiative with the support of the Biopharmcluster "Northern" and the investment company «XI Ventures». "The useful thing from personal experience," - said Vladimir Putin.

The best startups of the largest accelerator of Russia and Eastern Europe GenerationS-2016

April 25 in Moscow at the final of the largest in Russia and Eastern Europe startup accelerator GenerationS from RVC was named the best projects. Team Scanderm Pro - project track LifeScience, which operator is "XI Ventures", and an industrial partner of the Biopharmcluster "Northern", received the audience award.  

SPIEF-2017 opens up new possibilities for technological entrepreneurship in the field of Life Science

In the framework of St. Petersburg International Economic Forum Russian investment company "XI ventures" presented projects  its portfolio companies in the Life Science field.

Media about us

17.04.2017
The biopharmaceutical cluster "Northern" and OS "Neuronet" organize lectures on contemporary psycho

April 18 in the building "will be" the start of the course of lectures "Modern psychotechnics increase of efficiency of innovative development" for students and graduates of MIPT, organized by the biopharmaceutical cluster "Northern" and OS "Neuronet". Lectures will be read by the Laboratory staff of neurorobotic.

Read
08.04.2017
The winners of the GenerationS will be known on April 25

The finale of the largest in Russia and Eastern Europe start-up accelerator GenerationS will be held in Moscow in the concert hall Stadium Live. The total value of prizes exceeds 100 million rubles.

Read
27.03.2017
In the St. Petersburg clinic began testing a non-invasive glucometer

On 27 March, the company "brain Bits" started testing and clinical studies of the device for non-invasive glucometry. The tests are carried out at the endocrinology Department of the hospital №37 of the city of St. Petersburg. The study will involve 500 people. Completion of testing of non-invasive glucometer is scheduled for may 10 this year.

Read
10.01.2017
"XI VENTURES" MAKES ITS FIRST EXIT FROM A PREVIOUSLY-FUNDED PROJECT "LEOREX"

Russian investment company "XI Ventures" sold part of its stake in the project company OOO "Leorex" strategic partner - the company "Spetsmedtekhnika", specializing in the development, manufacture and sale of medical devices for special purposes, including for extreme conditions.

Read
20.12.2016
"XI Ventures" took part in the selection of finalists of the contest "Eureka! The concept of"

15 December 2016 at the faculty of Economics of MSU named after M. V. Lomonosov hosted the final of the annual competition "Eureka! The concept of" organized "Inpractice" in partnership with the Russian Foundation for basic research. Members of the expert jury selected the best innovative projects that were awarded grants in the amount of 2 000 000 rubles. Cyril Volynchik, development Director at the Russian investment company "KSI ventures", took part in the evaluation of projects of a direction "Bio".

Read
07.12.2016
The biopharmaceutical cluster "Northern" shared experience in the field of technological entrepreneurship with the participants of the innovative territorial cluster "Pushchino"

28 November-6 December on the basis of Biotechnological innovation territorial cluster "Pushchino" took place the educational program in the field of business innovation for entrepreneurs and young professionals, postgraduates and students of universities that plan to participate in the implementation of innovative projects in the suburbs. The event includes seminars and workshops on technology commercialization, investment attraction and training of innovative project presentations. Within the unit "Business modeling" Kirill Volynchik, development Director at Biopharmaceutical cluster "Northern", Director on development of "XI ventures" held a master-class "Strategy and the interaction with Seed funds in the field of living systems".

Read

Send order

attach presentation